Many patients enter clinical trials with the belief that by taking part in research, they will help other patients in the future. For that to happen, the results of this research must be transparent and fully available.
AllTrials co-founder Dr Ben Goldacre:
Once again we see that half of all trial results for currently used treatments are missing. While industry groups like the ABPI give false reassurance, and try to pretend that this problem has gone away, patients are being unnecessarily harmed. Industry, regulators, patient groups, professional bodies and the research community need to take action, show leadership, and address this problem urgently.
The same is true for research on all domains. It’s time all clinical trial results are reported. Patients, researchers, pharmacists, doctors and regulators everywhere will benefit from publication of clinical trial results. Wherever you are in the world please sign the petition: Thousands of clinical trials have not reported their results; some have not even been registered. Information on what was done and what was found in these trials could be lost forever to doctors and researchers, leading to bad treatment decisions, missed opportunities for good medicine, and trials being repeated. All trials past and present should be registered, and the full methods and the results reported. Join the AllTrials Campaing to call on governments, regulators and research bodies to implement measures to achieve this by signing the petition here.
[1] “RReACT Goes Global: Perils andPitfalls of Constructing a Global Open-Access Database of Registered Analgesic Clinical Trials and Trial Results,” by Troels Munch; Faustine L. Dufka; Kaitlin Greene; Shannon M. Smith; Robert H. Dworkin; Michael C. Rowbotham (DOI: http://dx.doi.org/10.1016/j.pain.2014.04.007). It appears online ahead of PAIN®, Volume 155, Issue 8 (August 2014) published by Elsevier.
Copyright AllTrials Campaign and shared under CC-BY-NC
